ARQ Wealth Advisors’s AbbVie ABBV Stock Holding History

ARQ Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$832K	Sell	3,286 -35	-1%	-$7.53K	0.1%	123
2026 Q1	$722K	Buy	+3,321	New	+$737K	0.13%	112

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ARQ Wealth Advisors's ABBV Position: Q2 2026 in Review

ARQ Wealth Advisors reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $7.53K and leaving 3,286 shares worth $832K. The position accounts for 0.1% of the portfolio, ranked #123.

ARQ Wealth Advisors first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

ARQ Wealth Advisors held 3,286 shares of AbbVie worth $832K as of Q2 2026.
ARQ Wealth Advisors sold 35 AbbVie shares in Q2 2026, an estimated $7.53K.
AbbVie made up 0.1% of ARQ Wealth Advisors's portfolio in Q2 2026, its #123 holding.
ARQ Wealth Advisors first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on ARQ Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.